These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5638964)

  • 1. [Hormone treatment in women with breast cancer. I. Effect of diethylstilbestrol dipropionate on the clinical course and on the excretion of estrogen in the urine of women with metastatic breast cancer].
    Schejbalová L; Vrtílek V; Kadlecová D
    Vnitr Lek; 1968 Mar; 14(3):273-6. PubMed ID: 5638964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy in women with breast cancer. II. Prognosis of the diethylstilbestrol effect from the urine estrogen level].
    Vrtílek V
    Vnitr Lek; 1970 Feb; 16(2):137-40. PubMed ID: 5434560
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
    Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
    Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endolumbar administration of hydrocortisone in the complex treatment of patients with generalized breast cancer].
    Pankov AK; Mindlin SS; Verkhovtseva AI
    Vopr Onkol; 1975; 21(5):99-104. PubMed ID: 1243210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of metastazing carcinoma of the breast. New therapeutic principle of anti-estrogen treatment].
    Henningsen B; Fey KH; Hocevar V
    Fortschr Med; 1974 May; 92(14):617. PubMed ID: 4829457
    [No Abstract]   [Full Text] [Related]  

  • 6. Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women.
    MacMahon B; Cole P; Brown JB; Paffenbarger R; Trichopoulos D; Yen S
    J Natl Cancer Inst; 1983 Feb; 70(2):247-50. PubMed ID: 6571932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of the metastasizing mammary carcinoma].
    Studer H; Dolder M
    Schweiz Med Wochenschr; 1966 Feb; 96(8):250-3. PubMed ID: 5983011
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.
    Palshof T; Mouridsen HT; Daehnfeldt JL
    Eur J Cancer (1965); 1980; Suppl 1():183-7. PubMed ID: 7032931
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of StilbostatR treatment efficiency in breast cancer by thermography.
    Zimel H; Mogos I; Maltezeanu G
    Neoplasma; 1977; 24(5):553-7. PubMed ID: 927612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
    Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
    Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
    [No Abstract]   [Full Text] [Related]  

  • 14. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy in metastatic breast cancer: clinical response and urinary gonadotrophins.
    Stewart JG; Skinner LG; O'Connor PJ
    Acta Endocrinol (Copenh); 1965 Nov; 50(3):345-56. PubMed ID: 5898100
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 5. Adjuvant endocrine therapy.
    Palshof T
    Can J Surg; 1981 Jul; 24(4):379-84. PubMed ID: 7023634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with breast cancer using electrovaginography.
    Mozden PJ; Parsons L
    Surg Forum; 1965; 16():120-2. PubMed ID: 5835114
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer.
    Levin J; Markham MJ; Greenwald ES; O'Connor JF; Zumoff B; Fukushima DK
    Anticancer Res; 1982; 2(6):377-80. PubMed ID: 7168557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of metastatic spread in triple-negative breast cancer.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Breast Cancer Res Treat; 2009 May; 115(2):423-8. PubMed ID: 18543098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.